Assembly Biosciences Inc.
ASMB | NASDAQ
$25.66
+$0.22 (+0.86%)
Sep 22, 2026, 12:48 PM ET · Market open
Market Data
Market Cap $504.15M
Enterprise Value $186.14M
Beta 1.13
Average Volume 223.22K
Shares Outstanding (Diluted) 18.85M
Shares Change YoY 146.26%
Institutional Ownership 80.29%
Exchange NASDAQ
ISIN US0453962070
Price Performance
Price Change 1M -26.5%
Price Change 3M -5.1%
Price Change 6M -11.3%
Price Change YTD -24.6%
Price Change 1Y 2.7%
Price Change 3Y 130.4%
Price Change 5Y -37.1%
1M CAGR (ann.) -4.7%
1Y CAGR (ann.) 14.2%
5Y CAGR (ann.) -8.5%
All-Time CAGR -15.7%
Valuation
PE Ratio 46.25
Forward PE 12.31
PEG Ratio 0.06
Forward PEG 0.12
PS Ratio 8.20
Forward PS 11.80
PB Ratio 1.65
P/FCF Ratio -13.07
P/Adj. FCF Ratio -11.15
P/OCF Ratio -12.47
EV/Sales 3.03
EV/EBIT 48.79
EV/EBITDA -76.32
EV/FCF -4.83
Earnings Yield 2.2%
FCF Yield -7.7%
Adj. FCF Yield -9.0%
Financial Health
Net Cash $318.01M
Total Debt $2.35M
Cash & Short-Term Investments $320.36M
Total Assets $330.83M
Current Ratio 13.99
Quick Ratio 13.99
Debt / Equity Ratio 0.01
Debt / EBITDA -0.96
Debt / FCF -0.06
OCF / Debt -16.37
Interest Coverage 0.00
Altman Z-Score 9.76
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 77.7%
Operating Profit Margin -14.3%
EBITDA Margin 0.1%
Net Profit Margin -0.1%
FCF Margin -62.7%
Adj. FCF Margin -73.6%
SBC / Revenue 8.9%
SBC Impact (per share) -17.3%
Returns
Return on Assets 0.0%
Return on Equity 0.0%
Return on Invested Capital -2.9%
Return on Capital Employed -2.9%
Return on Tangible Assets 0.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 51.6%
Revenue CAGR 5Y 11.5%
Revenue CAGR 10Y 12.9%
EPS CAGR 3Y 100.8%
EPS CAGR 5Y 57.0%
EPS CAGR 10Y 17.7%
FCF CAGR 3Y -133.7%
FCF CAGR 5Y 24.0%
FCF CAGR 10Y 1.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y -220.6%
Revenue Growth Next 3Y -23.7%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.66
EPS Growth Est (next Q) -9.0%
Revenue Est (next Q) $9.07M
Revenue Growth Est (next Q) -15.9%
Fair Value Estimates
Graham Number $14.16
Graham Upside -44.3%
Lynch Fair Value $13.75
Lynch Upside -46.0%
Price Target $51.67
Price Target Upside 103.1%
Cash Flow
Operating Cash Flow $-38.48M
Free Cash Flow $-38.57M
Adj. Free Cash Flow $-45.23M
FCF Per Share -$2.05
OCF Per Share -$2.04
OCF/S Ratio -51.4%
Income Statement
Revenue $61.47M
Gross Profit $44.83M
Operating Income $-8.8M
EBITDA $-2.44M
Net Income $-42K
EPS (Diluted) $0.55
Revenue / Employee $842.07K
Profit / Employee $-575.34
Employees 73
Add to Watchlist
Select watchlists to add or remove ASMB